To include your compound in the COVID-19 Resource Center, submit it here.

RaQualia scores

RaQualia one of the biggest ever biotech IPOs in Japan

RaQualia scores

In one of the largest biotech IPOs ever in Japan, RaQualia Pharma Inc. last week raised ¥6.4 billion ($79.4 million), giving it a post-money valuation of ¥21.5 billion ($266.6 million) and putting its deal among the top tier of biopharma IPOs for the year.

The company sold 4 million shares at

Read the full 510 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE